David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AL
2351
CALL
DELISTED
Air Lease Corp
AL
| $964K | ﹤0.01% |
+30,000
| New | +$852K |
|
2352
CALL
Capri Holdings
CPRI
$1.51B
| $963K | ﹤0.01% |
16,900
-140,600
| -89% | -$6.94M |
|
|
SRDX
2353
DELISTED
Surmodics
SRDX
| $963K | ﹤0.01% |
52,287
+1,605
| +3% | +$30.2K |
|
|
CIVI
2354
DELISTED
Civitas Solutions, Inc.
CIVI
| $955K | ﹤0.01% |
54,766
-27,035
| -33% | -$557K |
|
2355
Universal Electronics
UEIC
$56.3M
| $954K | ﹤0.01% |
15,396
-8,859
| -37% | -$472K |
|
|
RVNC
2356
DELISTED
Revance Therapeutics, Inc.
RVNC
| $954K | ﹤0.01% |
54,621
-105,318
| -66% | -$2.14M |
|
2357
Vitamin Cottage Natural Grocers
NGVC
$651M
| $953K | ﹤0.01% |
44,794
+20,073
| +81% | +$404K |
|
2358
Popular Inc
BPOP
$10.8B
| $950K | ﹤0.01% |
33,220
+859
| +3% | +$22.5K |
|
|
HIBB
2359
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $950K | ﹤0.01% |
26,470
-21,495
| -45% | -$717K |
|
2360
Ryder
R
$9.44B
| $949K | ﹤0.01% |
14,652
-25,519
| -64% | -$1.45M |
|
|
XNPT
2361
DELISTED
XENOPORT, INC.
XNPT
| $949K | ﹤0.01% |
210,464
-51,795
| -20% | -$239K |
|
2362
SL Green Realty
SLG
$4.24B
| $947K | ﹤0.01% |
10,095
-170,827
| -94% | -$15.6M |
|
|
AIMC
2363
DELISTED
Altra Industrial Motion Corp
AIMC
| $947K | ﹤0.01% |
34,083
+12,132
| +55% | +$290K |
|
|
AGTC
2364
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $947K | ﹤0.01% |
67,744
+44,561
| +192% | +$654K |
|
2365
CALL
Nucor
NUE
$56.2B
| $946K | ﹤0.01% |
20,000
-30,000
| -60% | -$1.22M |
|
|
XLRN
2366
DELISTED
Acceleron Pharma
XLRN
| $946K | ﹤0.01% |
35,858
-4,582
| -11% | -$133K |
|
2367
Heron Therapeutics
HRTX
$61.3M
| $943K | ﹤0.01% |
+49,670
| New | +$980K |
|
2368
Sociedad Química y Minera de Chile
SQM
$22.6B
| $941K | ﹤0.01% |
+47,019
| New | +$811K |
|
2369
NNN REIT
NNN
$8.85B
| $940K | ﹤0.01% |
20,349
-24,259
| -54% | -$1.05M |
|
|
SCTY
2370
PUT
DELISTED
SolarCity Corporation
SCTY
| $939K | ﹤0.01% |
38,200
-20,500
| -35% | -$585K |
|
|
XNET
2371
Xunlei
XNET
$323M
| $937K | ﹤0.01% |
153,381
+25,037
| +20% | +$154K |
|
|
CJES
2372
DELISTED
C&J ENERGY SVCS LTD
CJES
| $937K | ﹤0.01% |
+664,597
| New | +$1.41M |
|
|
DSKY
2373
DELISTED
IDREAMSKY TECHNOLOGY LTD ADS REPTSG SHS CL A
DSKY
| $935K | ﹤0.01% |
68,022
-96,598
| -59% | -$1.3M |
|
2374
PUT
Zions Bancorporation
ZION
$9.86B
| $932K | ﹤0.01% |
38,500
+15,000
| +64% | +$345K |
|
2375
CALL
Range Resources
RRC
$9.58B
| $929K | ﹤0.01% |
28,700
-135,000
| -82% | -$3.75M |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.